New Products

EL SEGUNDO, Calif. — Murad has announced the debut of Pore Reform, a skin care regimen that includes a Blackhead & Pore Clearing Duo to unclog and seal pores, shielding the skin from blackhead-causing dirt and debris.

Featuring Oxidation Reversal Complex, proprietary technology that helps reverse and prevent sebum oxidation, Blackhead & Pore Clearing Duo is clinically proven to reduce the formation of blackheads by an average of 58%, the company stated.

HOLZKIRCHEN, Germany — Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.

Sandoz, the generics arm of Swiss drug maker Novartis, said it had started a phase-3 trial of biosimilar etanercept, a knock-off version of Amgen's Enbrel, used to treat chronic plaque-type psoriasis.

NEW YORK — The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.

According to reports, the FDA approved a gel formulation of Merz's Naftin (naftifine), used to treat athlete's foot, known medically as tinea pedis.

A cream version of the drug is already approved, and the latest approval was based on two clinical trials of more than 1,700 patients, according to reports.

HYDERABAD, India — Dr. Reddy's Labs has launched a generic drug for treating epilepsy, the company said.

The Indian generic drug maker announced the launch of lamotrigine extended-release tablets in the 25-mg, 50-mg, 100-mg, 200-mg and 300-mg strengths. The drug is being distributed in bottle sizes of 30.

Lamotrigine extended-release tablets are a generic version of GlaxoSmithKline's Lamictal XR, branded and generic versions of which had sales of $300.5 million during the 12-month period that ended in April, according to IMS Health.

NEW YORK — Rally Labs recently introduced its Blowfish for Hangovers, a morning-after remedy that has a bit of a cult following in New York, into the drug channel the company noted. 

The Blowfish formulation contains a combination of aspirin and caffeine in an effervescent tablet specifically formulated for hangovers. The buffered formula helps rehydrate, restore alertness and provide relief for a headache, Rally Labs noted. 

MOUNTAIN VIEW, Calif. — A drug for treating obesity has become available through a network of about 8,000 retail pharmacies around the country, the drug's manufacturer said Monday.

Vivus said the drug, Qsymia (phentermine; topiramate) extended-release capsules would be available at Costco and Walgreens stores, including Duane Reade stores. The launch is happening ahead of the previously announced mid-July launch date.

CINCINNATI — This weekend marks the kick-off to Oral-B’s road trip across America, as it proves that even residents on Manual Street will not go back to their manual brush once they’ve experienced the “Wow” of the Deep Sweep power brush.

SAN FRANCISCO — MedFolio, a medical technology firm founded by a pharmacist, announced this week the availability of a new wireless electronic pillbox designed to help patients improve medication adherence.

The new wireless MedFolio device syncs medication adherence reports to a secure online cloud server that allows caregivers, family members and healthcare professionals — upon being granted access — to monitor whether medications are being taken as prescribed or to detect any problematic patterns.